You are here

Home » Reports

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

Displaying 1 - 10 of 127 results
 
  • Record 1 TO 127

  1. EXPANSION OF HUMAN UMBILICAL CORD BLOOD STEM CELLS

    SBC: Aastrom Biosciences, Inc.            Topic: N/A

    N/A

    SBIR Phase I 1997 Department of Health and Human Services

  2. Choosing a Plan for Minority & Undeserved Workers

    SBC: ABACUS HEALTH SOLUTIONS, LLC            Topic: N/A

    N/A

    SBIR Phase I 1994 Department of Health and Human Services

  3. A novel magnetic resonance detector for early diagnosis of bladder cancer recurre

    SBC: ABQMR, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): Bladder cancer is a common and costly disease. More than 60,000 new cases of bladder cancer are diagnosed each year in the U.S. It is the fourth most common cancer among men and the 10th among women, with a prevalence of about 500,000 in the US. Our compact NMR device will provide a rapid, accurate differential diagnosis of bladder cancer by detecting the tumor ...

    SBIR Phase I 2009 Department of Health and Human ServicesNational Institutes of Health

  4. Novel Small-molecule TNF-a Modulators as Chemoprotective Agents

    SBC: 21ST CENTURY THERAPEUTICS, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): Cisplatin is a widely used cytotoxic agent with therapeutic activity against various tumors, but also with substantial side effects, including nephrotoxicity, hepatotoxicity and myelosuppression. Therefore, a chemoprotective agent which reduces the side effects of cisplatin without affecting it efficacy would have significant clinical benefit. Currently, amifos ...

    SBIR Phase I 2009 Department of Health and Human ServicesNational Institutes of Health

  5. DEVELOPMENT OF NEW ANTI-FELINE LEUKEMIA VIRUS DRUGS

    SBC: ALBUQUERQUE AVIAN EXOTIC            Topic: N/A

    IN COLLABORATIVE STUDIES WITH THE UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE, WE HAVE OBTAINED PRELIMINARY DATA ON THE ANTIVIRAL PROPERTIES OF DERIVATIVES OF THE NATURAL PRODUCT GOSSYPOL. IN PARTICULAR, ONE DERIVATIVE NAMED GIL HAS SHOW PROMISING ACTIVITY IN THE TREATMENTOF DOMESTIC CATS INFECTED WITH FELINE LEUKEMIA VIRUS (FELV). ALSO NOTEWORTHY IS THE FACT THAT GIL SHOWS PROMISING IN VITRO ACTI ...

    SBIR Phase I 1992 Department of Health and Human Services

  6. TRAINING SECONDARY PREVENTION OF FETAL ALCOHOL SYNDROME

    SBC: Alcohol Self-control Program            Topic: N/A

    N/A

    SBIR Phase I 1997 Department of Health and Human Services

  7. SECONDARY PREVENTION OF ALCOHOLISM VIA COMPUTER SOFTWARE

    SBC: Alcohol Self-control Program            Topic: N/A

    N/A

    SBIR Phase I 1990 Department of Health and Human Services

  8. RECOMBINANT MONOCLONAL ANTIBODIES IN YEAST

    SBC: BioSavita, Inc.            Topic: N/A

    The use of monoclonal antibodies (MABs) in diagnostic and therapeutics applications is on the rise; yet there are limitations to the current hybridoma technology. There is a need to develop less expensive, novel and improved technologies for MAb production. The application of recombinant technology has made it possible to generate single chain, chimeric and humanized MAbs with desired specificity. ...

    SBIR Phase I 1997 Department of Health and Human Services

  9. Designed Bioactive Scaffolds for Mandibular Reconstruction

    SBC: TISSUE REGENERATION SYSTEMS, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): Craniomaxillafacial (CMF) reconstruction remains a significant challenge due to the complex geometry and the need to restore both esthetics and function, especially for large mandibular segmental defects resulting from tumor resection, trauma or congenital defects. The current clinical gold standard, vascularized free bone flap (VBF), still suffers significant ...

    SBIR Phase I 2009 Department of Health and Human ServicesNational Institutes of Health

  10. SILENT PUMP FOR LASER SMOKE REMOVAL AND STERILIZATION

    SBC: Ballena Systems Corp            Topic: N/A

    A SMOKE EVACUATION SYSTEM IS AN ESSENTIAL PART OF LASER SURGERY, BOTH IN RESEARCH AS WELL AS IN HUMAN SURGERY. CURRENT TECHNIQUES FOR THE REMOVAL OF SMOKE AND DEBRIS GENERATED DURING LASER SURGERY ARE INEFFICIENT, NOISY, AND EXPOSE THE SURGEONS AND SUPPORT PERSONNEL TO THE HAZARDS OF PATHOLOGICAL AIRBORNE AEROSOLS. THE AIRBORNE AEROSOLS ARE CURRENTLY REMOVED THROUGH VACUUM ACTION (AIR PUMPS) AND C ...

    SBIR Phase I 1992 Department of Health and Human Services
US Flag An Official Website of the United States Government